GSK 20% initiative - investing in development
AMREF partner pharmaceuticals company, GlaxoSmithKline has announced its commitment to reinvest 20% of profits made in the Least Developed Countries back into projects that strengthen the healthcare infrastructure in those countries.
Improving child survival, South Africa
Child mortality in South Africa is unacceptably high, with 62 out of every 1,000 children dying before they reach their fifth birthday. That figure is approximately 5 out of every 1,000 children in the UK.
Putting mothers and children first, South Sudan, Kenya, Tanzania
In sub-Saharan Africa maternal and child health rates remain unacceptably high. Every year in the region 200,000 mothers die in pregnancy. 1.5 million African children are left without a mother each year. Despite the world’s progress in meeting the Millennium Development Goals, those targets related, particularly to maternal health, remain far from reach.






Read AMREF's latest publications here

